DJO announced that it acquired orthopedic foot and ankle implant maker Trilliant Surgical for an undisclosed amount.
Dallas-based Colfax (NYSE:CFX) unit DJO’s acquisition is meant to support its focus on expansion into the high-growth U.S. foot and ankle market, which the company touts as a $1 billion market, according to a news release.
Trilliant’s product portfolio covers foot reconstruction/fixation procedures and the company additionally offers the novel Arsenal Foot Plating System, which features a design for greater flexibility and speed of implant placement. The companies believe the Arsenal system is poised to “be a plating leader.”
“As a foot and ankle champion since 2007, we are excited to join the DJO family and expand Trilliant Surgical’s positive patient impact globally,” Trilliant CEO Jon Olson said in the release. “DJO’s unparalleled commitment to new product development, their iconic brands and strong growth trajectory will accelerate Trilliant’s ability to grow, innovate and improve patient outcomes.”
The acquisition of Trilliant is DJO’s third major buy in recent months, as the company last month acquired LiteCure and its therapeutic laser technology. Before that, DJO completed its acquisition of total ankle and finger arthroplasty lines from Stryker in November 2020.
“Trilliant’s market-leading portfolio of foot and ankle solutions complements our acquisition of the STAR system and creates a dedicated foot and ankle business that significantly expands our mission of Powering Motion,” added DJO CEO Brady Shirley. “We are committed to building our reconstructive segment and believe that the foot and ankle space is a great fit for our focused innovation and solutions approach that has allowed DJO to be a growth leader in the upper extremity market for many years.”